Scroll to Top
/ Press Releases & Statements
Press Releases & Statements
IMI Launches Two New Calls to Appeal to a Wide Range of Stakeholders
18 December 2015
The world’s largest public-private partnership in life sciences, the Innovative Medicines Initiative (IMI), has launched two new Calls for proposals, offering stakeholders from a variety ...
New IMS Report Highlights the Importance of Biosimilar Competition on Patient Access and Treatment Cost of Biological Medicines
16 December 2015
The European pharmaceutical industry welcomes the new report by IMS Health on ‘The Impact of Biosimilar Competition’. The new report, which was prepared by IMS Health ...
Bulgarian MoU to Boost Patient Access to Innovative Medicines
03 December 2015
EFPIA welcomes the Memorandum of Understanding signed on 1 December 2015, between the Bulgarian Health Ministry and representatives of the pharmaceutical industry, doctors’ and patients’ ...
Annual Growth Survey 2016 and European Semester Offer a Sound Basis for a Debate on Improving Outcomes
30 November 2015
EFPIA welcomes the European Commission’s Annual Growth Survey (AGS) for 2016, which has recommended that EU countries promote actively social investment more broadly, including in ...
Responsible Antibiotics Use is Key to Addressing the Rise of AMR
17 November 2015
On the advent of European Antibiotics Awareness Day, EFPIA takes note of the serious challenges caused by antimicrobial resistance (AMR) and reiterates the industry’s commitment ...
EFPIA Responds to the Opinion of the Expert Panel of the Commission on Access to Health Services in the EU
06 November 2015
EFPIA welcomes the debate on access to health services, valuing its important contribution in the face of challenges to European health systems sustainability. It is ...
OECD report demonstrates the need for outcomes-based approach to healthcare in Europe
05 November 2015
EFPIA acknowledges the publication of the OECD report, “Health at a Glance 2015”, noting its contribution to the debate on the sustainability of health systems. ...
Protection of the medicines supply chain: The European Medicines Verification Organisation (EMVO) and the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, have signed an agreement on Conformity Assessments
04 November 2015
(26 October 2015 – Brussels – Strasbourg): EMVO and EDQM have come to an agreement on the performance of periodic conformity assessments of the European ...
EFPIA Statement in Response to Criticism of the Adaptive Pathways Project
23 October 2015
In response to criticisms voiced by certain NGOs and medical groups about the adaptive pathways pilot project and its aims, EFPIA would like to be ...
EU New Trade and Investment Strategy Will Boost Innovation and Patient Access
15 October 2015
EFPIA welcomes the European Commission’s new trade and investment strategy for the European Union as a comprehensive means of addressing existing barriers to trade in ...
Page 6 of 21
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman